Maravai LifeSciences Holdings,

Historical 13F Holders

Symbol
MRVI
CUSIP
56600D107
All holders as of
Q2 2026
Type
Equity
Class
COM CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 56600D107 since 12/18/2024, newest first.

Filer % of Class Filed
Millennium Management LLC 13G
5.2% 9/29/2026
Event 9/22/2026
Stuart Feldman 13G/A Amendment 4
2.5% 8/13/2026
Event 6/30/2026
Millennium Management LLC 13G
4.7% 6/29/2026
Event 6/23/2026
Millennium Management LLC 13G
4.96% 6/23/2026
Event 6/16/2026
12 West Capital Management LP 13G/A Amendment 5
4.9% 5/15/2026
Event 3/31/2026
Stuart Feldman 13G/A Amendment 3
7.1% 5/14/2026
Event 3/31/2026
Millennium Management LLC 13G
4.9% 5/12/2026
Event 5/6/2026
12 West Capital Management LP 13G/A Amendment 4
6.2% 2/17/2026
Event 12/31/2025
Stuart Feldman 13G/A Amendment 2
5.5% 2/13/2026
Event 12/31/2025
Stuart Feldman 13G/A Amendment 1
6.2% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A Amendment 5 4.9% 10/31/2025
Event 9/30/2025
BlackRock, Inc. 13G/A Amendment 1 5.9% 10/17/2025
Event 9/30/2025
Vanguard Group Inc 13G/A Amendment 4 6.5% 7/29/2025
Event 6/30/2025
Stuart Feldman 13G
4.8% 5/29/2025
Event 5/21/2025
12 West Capital Management LP 13G/A Amendment 3
8.2% 1/28/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 11 198 k $1.52 M
2026 Q2 188 144 M $900 M
2026 Q1 167 121 M $344 M
2025 Q4 169 130 M $424 M
2025 Q3 168 131 M $376 M
2025 Q2 159 130 M $313 M
2025 Q1 197 133 M $293 M
2024 Q4 198 153 M $834 M
2024 Q3 226 148 M $1.23 B
2024 Q2 217 150 M $1.07 B
2024 Q1 221 141 M $1.23 B
2023 Q4 234 138 M $906 M
2023 Q3 218 136 M $1.36 B
2023 Q2 236 127 M $1.58 B
2023 Q1 232 128 M $1.79 B
2022 Q4 224 129 M $1.84 B
2022 Q3 214 131 M $3.34 B
2022 Q2 226 131 M $3.73 B
2022 Q1 248 128 M $4.52 B
2021 Q4 246 128 M $5.36 B
2021 Q3 238 128 M $6.27 B
2021 Q2 207 114 M $4.77 B
2021 Q1 152 98.4 M $3.51 B
2020 Q4 124 97.4 M $2.73 B